… Fluids remain one of the mostly widely used and abused medical therapies and their
management is too often delegated to the most junior members of the medical team. No randomized…

Acute kidney injury (AKI) is now recognized as a heterogeneous syndrome that not only
affects acute morbidity and mortality, but also a patient’s long-term prognosis. In this narrative …

Acute kidney injury (AKI) is a frequent complication of critical illness and carries a significant
risk of short- and long-term mortality, chronic kidney disease (CKD) and cardiovascular …

The immunodominant epitope of myelin basic protein, Ad-9, is encephalitogenic in H-2”
mice. We have previously demonstrated that this epitope displays low affinity for IA” and have …

In patients with acute kidney injury (AKI), optimization of systemic haemodynamics is central
to the clinical management. However, considerable debate exists regarding the efficacy, …

Acute kidney injury (AKI) is a heterogeneous clinical syndrome that has multiple aetiologies,
variable pathogenesis and diverse outcomes. However, these heterogeneities are not …

In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) published a guideline on the
classification and management of acute kidney injury (AKI). The guideline was derived from …

Introduction During critical illness, oliguria is often used as a biomarker of acute kidney
injury (AKI). However, its relationship with the subsequent development of AKI has not been …

Postoperative acute kidney injury (PO-AKI) is a common complication of major surgery that is
strongly associated with short-term surgical complications and long-term adverse outcomes…

Renal replacement therapies (RRTs) represent a cornerstone in the management of severe
acute kidney injury. This area of intensive care and nephrology has undergone significant …